| Thrombotic microangiopathy following onasemnogene abeparvovec for spinal muscular atrophy: a case series DH Chand, C Zaidman, K Arya, R Millner, MA Farrar, FE Mackie, ... The Journal of pediatrics 231, 265-268, 2021 | 141 | 2021 |
| Combination molecular therapies for type 1 spinal muscular atrophy Y Harada, VK Rao, K Arya, NL Kuntz, CJ DiDonato, ... Muscle & nerve 62 (4), 550-554, 2020 | 64 | 2020 |
| Sneddon syndrome: a comprehensive overview D Samanta, S Cobb, K Arya Journal of Stroke and Cerebrovascular Diseases 28 (8), 2098-2108, 2019 | 53 | 2019 |
| Spinal muscular atrophy care in the COVID‐19 pandemic era A Veerapandiyan, AM Connolly, RS Finkel, K Arya, KD Mathews, ... Muscle & nerve 62 (1), 46-49, 2020 | 49 | 2020 |
| EEG asymmetry and BIS/BAS among healthy adolescents M Schneider, L Chau, M Mohamadpour, N Stephens, K Arya, A Grant Biological psychology 120, 142-148, 2016 | 34 | 2016 |
| Congenital herpes simplex ND Fernandes, K Arya, R Ward | 26 | 2018 |
| An expanded access program of risdiplam for patients with Type 1 or 2 spinal muscular atrophy JM Kwon, K Arya, N Kuntz, HC Phan, C Sieburg, KJ Swoboda, ... Annals of clinical and translational neurology 9 (6), 810-818, 2022 | 20 | 2022 |
| Prevalence of epileptiform discharges in healthy 11-and 12-year-old children AC Grant, L Chau, K Arya, M Schneider Epilepsy & Behavior 62, 53-56, 2016 | 19 | 2016 |
| Thrombotic Microangiopathy (TMA): a potential adverse reaction post Zolgensma (onasemnogene abeparvovec-xioi) therapy for Spinal Muscular Atrophy (SMA)(5483) N Prabhu, E Saylam, C Louis, M Moss, R Millner, D Douglass, ... Neurology 94 (15_supplement), 5483, 2020 | 13 | 2020 |
| Simple partial seizure A Kumar, K Maini, K Arya, S Sharma | 12 | 2018 |
| Epilepsia partialis continua Z Khan, K Arya, PC Bollu | 10 | 2018 |
| Electroclinical findings of SYNJ1 epileptic encephalopathy D Samanta, K Arya Journal of Pediatric Neurosciences 15 (1), 29-33, 2020 | 9 | 2020 |
| Abnormal spontaneous electromyographic activity [updated 2022 May 8] L Davalos, K Arya, H Kushlaf StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing, 2022 | 6 | 2022 |
| Frequency, predictors, and outcome of seizures in patients with myelomeningocele: single-center retrospective cohort study C Karakas, E Fidan, K Arya, T Webber, JB Cracco Journal of child neurology 37 (1), 80-88, 2022 | 6 | 2022 |
| BAG3 myopathy presenting with prominent neuropathic phenotype and no cardiac or respiratory involvement: a case report and literature review L Malatesta, K Arya, M Gokden, V Stefans, A Veerapandiyan Journal of Clinical Neuromuscular Disease 21 (4), 230-239, 2020 | 5 | 2020 |
| Seizure Precautions A Al Sawaf, K Arya, N Murr | 5 | 2019 |
| Goedeker, 622 NL, Dharnidharka, VR, Dandamudi, R., and Reyna, SP (2021). Thrombotic 623 Microangiopathy Following Onasemnogene Abeparvovec for Spinal Muscular Atrophy: 624 A … DH Chand, C Zaidman, K Arya, R Millner, MA Farrar, FE Mackie J Pediatr 231, 265-268, 0 | 4 | |
| Athetoid cerebral palsy X Li, K Arya | 3 | 2020 |
| Galactokinase Deficiency PK Ramani, K Arya | 3 | 2020 |
| Combination therapy with nusinersen and AVXS-101: a real-world clinical experience (4152) Y Harada, K Arya, G Napchan-Pomerantz, R Kauffmann, A Agarwal, ... Neurology 94 (15 Supplement), 2020 | 2 | 2020 |
